Physician profile
Brandy Fleischer
NPI 1215104518
$1,941.91
in general payments reported to CMS, 2019-2025
17 companies · $585 in 2025
The $585 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $569 · 2023: $265 · 2024: $523 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,008.00 | 2022-2025 | |
| Madrigal Pharmaceuticals | $119.29 | 2024 | Rezdiffra |
| Qol Medical, LLC | $105.29 | 2022-2024 | Sucraid |
| Daiichi Sankyo INC. | $102.68 | 2022 | |
| Janssen Biotech, INC. | $98.64 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.82 | 2022-2023 | Trulance |
| Novo Nordisk INC | $76.08 | 2025 | Wegovy |
| Pfizer INC. | $66.23 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.91 | 2022-2025 | Entyvio |
| Celgene Corporation | $46.55 | 2022-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $42.69 | 2024-2025 | Voquezna |
| Medtronic, INC. | $39.60 | 2024-2025 | Gi Genius, Pillcam |
| Ironwood Pharmaceuticals, INC | $36.93 | 2022 | |
| Ardelyx, INC. | $21.42 | 2023 | Ibsrela |
| Braintree Laboratories, INC. | $13.17 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $12.87 | 2023 | |
| Lilly USA, LLC | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Fleischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.